No CrossRef data available.
Article contents
Combinación de venlafaxina y clomipramina
Published online by Cambridge University Press: 12 May 2020
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Cartas al editor
- Information
- Copyright
- Copyright © European Psychiatric Association 1997
References
Bibliografía
Baldessarini, RJ. Drugs and the treatment of psychiatric disorders. In: Hardman, JGLimbird, LE, Molinoff, PB, Ruddon, RW, Goodman Gillman, A, eds. Goodman & Gilman ‘s. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996; 399-459.Google Scholar
Benazzi, F. Urinary retention with venlafaxine - haloperidol combination. Phamacopsychiatry, in press.Google Scholar
Benazzi, F, Venlafaxine - fluoxetine - nortriptyline interaction. Submitted for publication, a.Google Scholar
Benazzi, F, Anticholinergic toxic syndrome with venlafaxine - desipramine combination. Submitted for publication, b. Ereshefsky L. Drug-drug interactions involving antidepressants: focus on venlafaxine. J Cin Psychopharmacol 1996; 16 (suppl 2): 37S-53S.Google Scholar
Nemeroff, CB, Lindsay De Vane C, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996; 153: 11-20.CrossRefGoogle Scholar
Physician's Desk Reference, 50 edition. Montvale, NJ: Medical Economics Company, 1996: 2719-23.Google Scholar
Preskorn, SH. Pharmacokinetics of antidepressant: why and how they are relevant to treatment. J Clin Psychiatry 1993; 54 (suppl 9): 14-34.Google ScholarPubMed
Preskorn, SH. Reducing the risk of drug-drug interactions: a goal of rational drug development. J Clin Psychiatry 1996; 57 (suppl 1): 13-16.Google ScholarPubMed
You have
Access